Advertisement
Fennec Pharmaceuticals Inc. (FENC)
NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Follow
At close: 04:00PM EDT
After hours:
| Previous Close | 4.6500 |
| Open | 4.7200 |
| Bid | 4.6400 x 100 |
| Ask | 4.6900 x 100 |
| Day's Range | 4.5800 - 4.8592 |
| 52 Week Range | 4.0900 - 11.9200 |
| Volume | |
| Avg. Volume | 83,984 |
| Market Cap | 127.244M |
| Beta (5Y Monthly) | 0.25 |
| PE Ratio (TTM) | 66.43 |
| EPS (TTM) | 0.0700 |
| Earnings Date | Nov 04, 2024 - Nov 08, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 15.50 |
Simply Wall St.The past three years for Fennec Pharmaceuticals (NASDAQ:FENC) investors has not been profitable
In order to justify the effort of selecting individual stocks, it's worth striving to beat the returns from a market...
GlobeNewswireFennec Pharmaceuticals to Participate in Upcoming Investor Conferences
RESEARCH TRIANGLE PARK, N.C., Sept. 05, 2024 (GLOBE NEWSWIRE) -- Fennec Pharmaceuticals Inc. (NASDAQ:FENC; TSX: FRX), a commercial stage specialty pharmaceutical company, today announced that the Company will be participating in upcoming investor conferences. The management team will also host one-on-one investor meetings at the conferences. Conference Details: Event: H.C. Wainwright Global Investment ConferenceDate: September 11, 2024Time: Company Presentation at 12:00 p.m. – 12:30 p.m. ETLocat
Advertisement
Advertisement
Advertisement
© 2024 Yahoo. All rights reserved.